IMARC Group, a leading market research company, has recently releases report titled “Anti-Obesity Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028”, Offers a comprehensive analysis of the industry, which comprises insights on the market.

How Big is the Anti-Obesity Drugs Market?

The global anti-obesity drugs market size reached US$ 2.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 4.0 Billion by 2028, exhibiting a growth rate (CAGR) of 11.7% during 2023-2028.

Industry Overview of Anti-Obesity Drugs

Anti-obesity drugs, also known as weight-loss medications, are prescribed as a part of a comprehensive weight-loss program that includes lifestyle modifications, such as dietary changes and increased physical activities. They are intended for individuals with a body mass index (BMI) above a certain threshold or those with obesity-related health conditions. They are typically prescribed under the supervision of healthcare professionals and are not intended for cosmetic weight loss purposes. As they assist in reducing feelings of hunger, promoting satiety, absorbing fat, and increasing metabolism, the demand for anti-obesity drugs is increasing around the world.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/anti-obesity-drugs-market/requestsample

What are the growth prospects and trends in the anti-obesity drugs industry?

At present, the growing rate of obesity among the masses due to changing lifestyles and decreasing exercise practices represents one of the major key factors influencing the market positively.

In addition, the rising awareness about healthy lifestyles among individuals is providing lucrative growth opportunities to industry investors. Besides this, key players are investing in research and development (R&D) activities to introduce drugs that can counter both obesity and type 2 diabetes. Moreover, the rising intake of junk food and fast food products among youngsters is propelling the growth of the market.

Apart from this, the increasing number of approvals of anti-obesity medications (AOMs) that help regulate appetite and food cravings is strengthening the growth of the market.

Leading Companies Operating in the Global Anti-Obesity Drugs Industry:

  • Boehringer Ingelheim International GmbH
  • Currax Pharmaceuticals LLC
  • Gelesis
  • GlaxoSmithKline plc
  • Merck & Co. Inc.
  • Norgine B.V.
  • Novo Nordisk A/S
  • Pfizer Inc.
  • Rhythm Pharmaceuticals Inc.
  • SHIONOGI & Co. Ltd.
  • Takeda Pharmaceutical Company Limited
  • Vivus LLC.

Anti-Obesity Drugs Market Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Drug Class:

  • Peripherally Acting Drugs
  • Centrally Acting Drugs

Breakup by Drug Type:

Breakup by Distribution Channel:

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC Group’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163